drugset / Trial / NCT06371196

Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule

NCT06371196 ↗

Phase 4 Unknown 60 enrolled Mei Han
NaSingle-groupOpen-labelTreatment

Summary

1. Explore the effect of Babaodan Capsule on the serum total bilirubin level of primary biliary cholangitis patients with elevated total serum bilirubin; 2. To observe the positive intervention effect of Babaodan Capsule on the clinical symptoms of primary biliary cholangitis patients with elevated total bilirubin.

Timeline

Start
2024-04-25
Primary completion
2025-07-25
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Babaodan Capsule Unknown 0.6 g Oral